We would like to congratulate Professor Gareth Evans on his recent MBE award at the King's Birthday Honours 2026.
Professor Gareth Evans, Emeritus Professor of Medical Genetics at The University of Manchester and Consultant in Medical Genetics at Manchester University NHS Foundation Trust, has significantly contributed to advancing the field of inherited research and to the set-up of a national specialised NF2 schwannomatosis service.
.
We present a letter written from Professor Benger (Chief Medical Officer, Deputy CEO and Interim Director of the Centre of Guidelines, and NICE National Institute for Health and Care Excellence) with regards to the recent discussion on Tumour Treating Fields (TTFs).
We present a letter written to Professor Benger (Chief Medical Officer, Deputy CEO and Interim Director of the Centre of Guidelines, and NICE National Institute for Health and Care Excellence) with regards to the view of BTNW on Tumour Treating Fields and also our view forward.
We are please to present the evidence from Dr Matthew Williams with regards to the efficacy of Tumour Treating Fields for patients diagnosed with Glioblastoma.
We are proud to present the newly created Optune Support website with link as below:
Brain Tumour North West (BTNW), involves the Universities of Lancashire, Hull, Lancaster, Leeds, Liverpool, Manchester, Manchester Metropolitan and Wolverhampton, and together with the Lancashire Teaching Hospitals, Clatterbridge Centre for Oncology and Walton Centre NHS Trusts, in a new strategic alliance designed to consolidate and exploit clinical and research-based brain tumour expertise which currently exists within the region.
Leading edge research
